SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 10.2% Passive Stake in Chemours Co.

FMR LLC and Abigail P. Johnson have jointly filed an amended Schedule 13G, reporting a combined beneficial ownership of 10.2% of Chemours Co.'s common stock as of January 31, 2025.

Summary

• FMR LLC and Abigail P. Johnson collectively beneficially own 15,258,748.68 shares of Chemours Co. common stock.
• This ownership represents 10.2% of the total outstanding common stock of Chemours Co.
• The filing is an Amendment No. 13 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Chemours Co.
• FMR LLC, a Delaware-organized entity, holds sole voting power over 14,729,719.44 shares and sole dispositive power over 15,258,748.68 shares.
• Abigail P. Johnson, a U.S. citizen, holds sole dispositive power over 15,258,748.68 shares.
• Several FMR LLC subsidiaries, including FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Strategic Advisers LLC, are identified as entities that beneficially own shares, with Fidelity Management & Research Company LLC owning 5% or more.
• Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of FMR LLC's Series B voting common shares (representing 49% of voting power) and form a controlling group with respect to FMR LLC through a shareholders' voting agreement.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership and typically carries a neutral sentiment, indicating a passive investment stake without explicit positive or negative implications for the issuer's performance or strategy.

Positives

• FMR LLC and Abigail P. Johnson maintain a significant beneficial ownership stake of 10.2% in Chemours Co., indicating continued investment interest from a major institutional investor.
• The reporting persons certify that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, suggesting a passive and stable investment approach.

Risks

• The reporting persons explicitly state that the securities were not acquired or held for the purpose of changing or influencing the control of Chemours Co., which mitigates potential concerns about activist investor intervention.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Chemours Co.'s future performance or strategic outlook.

Industry Context

Chemours Co. operates in the chemical industry. This filing indicates that FMR LLC, a prominent asset management firm, maintains a significant passive investment in a company within this sector, reflecting ongoing institutional interest in the chemical industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which can be interpreted as a signal of continued confidence from a major investor.
• Management: Indicates the presence of a large, passive investor, which typically implies less pressure for immediate strategic or operational changes compared to an activist investor.

Key Dates

Keywords

Chemours Co, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing, ownership stake, chemical industry